Cortexyme () P/FCF US GAAP (year values) |
||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
P/FCF | 0.00 | 0.00 | -32.1 | -15.9 | -5.95 | -1 505 | ||
Changes by years, y/y, % | -50% | -63% |
Cortexyme. P/FCF
Cortexyme. P/FCF, changes, %
Cortexyme () P/FCF US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
P/FCF | -27.5 | -44.1 | -5.95 | -2.85 | -1 505 | -1 505 | ||
Changes by years, y/y, % | -9% | +45% | -63% | -86% | +5 368% | |||
Changes by quarters, q/q, % | +39% | +60% | -86% | -52% | +52 787% |